The abortion pill that has serious adverse effects for 1 in 10 women, finds the study
A new study has exhibited “serious adverse events” linked to the mifepristone, also known as the “abortive pill.”
Mifepristone is a “pregnancy blocker” that is used in combination with another medication, misoprostol, to finish pregnancies, according to Mayo Clinic.
It is also used to handle early involuntary abortions, since it helps prepare the body to empty the uterus.
The use of the abortion pill has shot in recent years, reveals a new report: “substantial increase”
The research carried out by the Center for Ethics and Public Policies in Washington, DC, has revealed that the rate of serious side effects is 22 times higher than that indicated on the drug label approved by the FDA.
After going through an abortion assisted by Mifepristone, almost 11% of women, more than one in 10, reported having experienced “infection, bleeding or other serious or potentially deadly adverse event,” according to the study summary.
A new study has exhibited “serious adverse events” linked to the mifepristone, also known as the “abortive pill.” (Istock)
The study used insurance claims data that include more than 865,000 abortions of medications prescribed between 2017 and 2023, resulting in what is described as the largest data set on chemical abortion.
Abortion on request: These 6 states allow women to obtain drugs that end pregnancy by phone or online
“On the contrary, the current drug label approved by the FDA is based on the results of 10 clinical trials with a total of 30,966 women, less than 0.5 percent of which allegedly experienced serious adverse reactions,” says the study.
“Some of these essays were carried out 42 years ago.”
The authors of the study, Jamie Bryan Hall, director of EPPC data analysis, and Ryan T. Anderson, president of EPPC, described the results as a “truly shocking and sad reality.”
The study used insurance claims for more than 865,000 abortions of medications prescribed between 2017 and 2023.
“We were not surprised exactly these findings, since other studies of smaller data sets have found significant security problems with chemical medications, particularly after the Obama and Biden administrations eliminated important safety protections of the FDA that were required when the chemical medicine was first approved for the first time,” said the authors in a statement sent to News Digital.
“The greatest limitation, which we are working to address, is that there is no insurance code for death, and unfortunately, we know that women die from complications resulting from the abortive pill.”
Almost 11% of women reported having experienced “infection, bleeding or other serious or potentially mortal adverse event,” according to the study summary. (Istock)
According to the study, the researchers are asking the FDA to restore the original security protections that required when they approved Mifepristona, stating that “women deserve the truth.”
Christina Francis, MD, CEO of the American Association of Obgyns Pro Life, based in Ft. Wayne, Indiana, did not participate in the investigation, but commented on the importance of the result.
Click here to get the News application
“The findings of this study, which analyzes almost 900,000 drug -induced abortions, are aligned with what I have seen in my two decades of practice as an OB gynec, during which they have served many women who have lied about drug safety for abortion and suffered significant complications of them,” he told News Digital.
Francis concluded that almost 71,000 women probably suffered this type of serious complications in 2023, based on numbers of the Guttmacher Institute.
Mifepristone is also used to handle early involuntary abortions, since it helps prepare the body to empty the uterus. (Istock)
“This should serve as an FDA attention call that the complications rate is more than 20 times higher than it has previously stated, and it is a public health crisis that must be investigated immediately,” he said.
“Women deserve informed consent about the potentially mortal dangers of these drugs.”
Potential limitations
Professor Jessie Hill, an expert in health law at Case Western University Reserve at Cleveland, Ohio, also reviewed the study findings.
She declared that Mifepristone has been one of the most studied medications since her approval in the US. UU. 25 years ago, claiming that she is also “one of the safest.”
Click here to register in our health newsletter
Hill pointed out that the EPPC study is not revised by pairs and questioned his “potential bias.”
“The study uses insurance claims data, but insurance claims are an imperfect indicator of causal medical results,” Digital News told News. “They often lack context: a complaint of hemorrhage, for example, may not be causally linked to the mifepristone itself.”
According to the Guttmacher Institute, approximately 63% of all abortions in the US. In 2023, they were abortions of medicines, according to the Guttmacher Institute. (Istock)
Hill also opposed the comparison of modern claims data with the FDA clinical trial data.
“Clinical trials have rigorous standards to define and inform adverse events. Claims data are generated for billing purposes, not scientific analysis and, often, contain or poorly classify events.”
“Insurance claims are an imperfect indicator of causal medical results.”
Hill also pointed out that the legal standard for the regulation of FDA medications is not “any risk”, and that all medications have adverse event rates.
“The exaggeration of risks without weighing the benefits distorts the regulatory framework,” he said.
For more health articles, visit www.Newsnews.com/health
According to the Guttmacher Institute, approximately 63% of all abortions in the US. In 2023, they were abortions of medicines, according to the Guttmacher Institute. This was a 53% increase in 2020.
News Digital contacted the FDA and the manufacturer of Mifepristone to comment.
Melissa Rudy is a senior health editor and a member of the lifestyle in News Digital. The advice of history can be sent to melissa.rudy@News.com.